Company: CDT
Filing Date: 2025-02-19
Form Type: 8-K
Source: 0001493152-25-007573
Chunk: 1

Company: CDT Equity Inc.
Filing Date: 2025-02-19
Form: 8-K
Item: Item 8.01
Chunk 1
---
Item
8.01. Other Events

In
an effort to reduce its outstanding debt to satisfy compliance with certain Nasdaq deficiencies, on February 13, 2025, the

As
previously disclosed, on August 6, 2024, as subsequently amended in October and November of 2024, the Company had entered into a Senior
Secured Promissory Note (the “ Senior Note”) and a security agreement with the Lender (the “ Security Agreement”),
pursuant to which the Company issued and sold the Senior Note in the original principal amount of $2,650,000, inclusive of a $500,000
original issuance discount. As a result of satisfying its obligations under the Senior Note, all of the Company’s assets are once
again free and clear of any liens, security interests or encumbrances.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                         CONDUIT PHARMACEUTICALS INC.                               
  February 19, 2025      By:                               /s/ David                
                         Name:                             David Tapolczay          
                         Title:                            Chief Executive Officer